MARKET

EVOK

EVOK

Evoke Pharma Inc
NASDAQ
10.93
-0.01
-0.09%
After Hours: 10.94 +0.01 +0.09% 19:24 12/05 EST
OPEN
10.92
PREV CLOSE
10.94
HIGH
10.94
LOW
10.92
VOLUME
26.31K
TURNOVER
--
52 WEEK HIGH
10.94
52 WEEK LOW
1.940
MARKET CAP
18.83M
P/E (TTM)
-5.6835
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EVOK last week (1124-1128)?
Weekly Report · 5d ago
U.K. Gambling Stocks Benefit From Diversified Revenue -- Market Talk
Dow Jones · 11/27 10:35
Weekly Report: what happened at EVOK last week (1117-1121)?
Weekly Report · 11/24 10:31
Evoke Pharma Reports Increased Sales Amid Ongoing Losses
TipRanks · 11/18 06:50
Weekly Report: what happened at EVOK last week (1110-1114)?
Weekly Report · 11/17 10:32
Evoke Pharma’s Merger Uncertainty: Potential Risks to Business Operations and Financial Health
TipRanks · 11/16 06:00
Evoke Pharma GAAP EPS of -$0.45, revenue of $4.28M
Seeking Alpha · 11/13 12:27
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Reuters · 11/13 12:14
More
About EVOK
Evoke Pharma, Inc. is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal disorders and diseases. It develops, commercializes and markets GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults. Gimoti is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist with pro-motility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti offers systemic delivery by nasal spray administration. It has developed a nasal formulation of metoclopramide to provide its targeted patient population with recurrent symptoms of diabetic gastroparesis with a product that is systemically delivered as an alternative to the oral or intravenous routes of administration. The nasal formulation delivers metoclopramide to patients with delayed gastric emptying and/or frequent vomiting.

Webull offers Evoke Pharma Inc stock information, including NASDAQ: EVOK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVOK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EVOK stock methods without spending real money on the virtual paper trading platform.